Inventor · disambiguated record
Maria Vitiello
Also filed as: VITIELLO MARIA · VITIELLO MARIA A · VITIELLO MARIA ANTONELLA · VITIELLO MARIA ANTONIA
4 granted patents·9 pending applications·212 citations·filing 1994–2015
81Inventor score
Top patents by PatentIndex Score
13 records- 0190US6419931B1Compositions and methods for eliciting CTL immunityEPIMMUNE INC·Filed 1994·Granted Jul 16, 2002·94 cites·27 claims
- 0284US6689363B1Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositionsEPIMMUNE INC·Filed 1999·Granted Feb 10, 2004·69 cites·55 claims
- 0372US7611713B2Inducing cellular immune responses to hepatitis B virus using peptide compositionsPHARMEXA INC·Filed 2003·Granted Nov 3, 2009·5 cites·5 claims
- 0472US6322789B1HLA-restricted hepatitis B virus CTL epitopesEPIMMUNE INC·Filed 1995·Granted Nov 27, 2001·44 cites·22 claims
- 0560US2007083333A1Modeling of systemic inflammatory response to infectionVITIELLO MARIA A·Filed 2004·Application pending·0 cites
- 0659US2010068228A1Inducing Cellular Immune Responses to Hepatitis B Virus Using Peptide and Nucleic Acid CompositionsPHARMEXA INC·Filed 2009·Application pending·0 cites
- 0753US2003099634A1Compositions and methods for eliciting CTL immunityFiled 2002·Application pending·0 cites
- 0852US2008160089A1Vaccine delivery compositions and methods of useMEDIVAS LLC·Filed 2007·Application pending·0 cites
- 0950US2007160622A1Method for assembling a polymer-biologic delivery compositionMEDIVAS LLC·Filed 2006·Application pending·0 cites
- 1048US2011097352A9Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositionsPHARMEXA INC·Filed 2007·Application pending·0 cites
- 1144US2007059799A1Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositionsPHARMEXA INC·Filed 2006·Application pending·0 cites
- 1237US2002119121A1Compositions and methods for inducing specific cytolytic T cell responsesFiled 2001·Application pending·0 cites
- 1336US2015140041A1Personalized cancer vaccines and adoptive immune cell therapiesPERSIMMUNE INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →